Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-chloro-2-(trifluoroMethyl)benzyl)-1H-indazole-5-carbaldehyde is a chemical compound belonging to the class of indazole derivatives. It is characterized by a benzyl-substituted indazole structure with a chloro and trifluoroMethyl substituent on the benzyl ring. 1-(4-chloro-2-(trifluoroMethyl)benzyl)-1H-indazole-5-carbaldehyde features a carbaldehyde functional group attached to the indazole ring, which contributes to its potential applications in medicinal chemistry, pharmaceuticals, and agrochemicals. Its unique structural features and chemical properties make it a promising candidate for research and drug discovery efforts.

1312704-84-9

Post Buying Request

1312704-84-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1312704-84-9 Usage

Uses

Used in Pharmaceutical Industry:
1-(4-chloro-2-(trifluoroMethyl)benzyl)-1H-indazole-5-carbaldehyde is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its structural diversity and potential biological activities make it a valuable asset in the development of new drugs, particularly those targeting specific receptors or enzymes.
Used in Agrochemical Industry:
In the agrochemical industry, 1-(4-chloro-2-(trifluoroMethyl)benzyl)-1H-indazole-5-carbaldehyde is utilized as a building block for the creation of novel agrochemicals. Its unique chemical properties allow for the development of compounds with enhanced pesticidal, herbicidal, or fungicidal properties, contributing to more effective crop protection strategies.
Used in Research and Drug Discovery:
1-(4-chloro-2-(trifluoroMethyl)benzyl)-1H-indazole-5-carbaldehyde serves as an important research tool in the field of drug discovery. Its structural features and potential biological activities make it a suitable candidate for studying the mechanisms of various diseases and for the development of targeted therapeutic agents. 1-(4-chloro-2-(trifluoroMethyl)benzyl)-1H-indazole-5-carbaldehyde can also be used to explore new chemical reactions and synthetic pathways, further expanding the scope of chemical research.

Check Digit Verification of cas no

The CAS Registry Mumber 1312704-84-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,7,0 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1312704-84:
(9*1)+(8*3)+(7*1)+(6*2)+(5*7)+(4*0)+(3*4)+(2*8)+(1*4)=119
119 % 10 = 9
So 1312704-84-9 is a valid CAS Registry Number.

1312704-84-9Relevant academic research and scientific papers

Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents

Patch, Raymond J.,Huang, Hui,Patel, Sharmila,Cheung, Wing,Xu, Guozhang,Zhao, Bao-Ping,Beauchamp, Derek A.,Rentzeperis, Dionisios,Geisler, John G.,Askari, Hossein B.,Liu, Jianying,Kasturi, Jyotsna,Towers, Meghan,Gaul, Micheal D.,Player, Mark R.

, p. 830 - 853 (2017/07/25)

Estrogen-related receptor α (ERRα) is an orphan nuclear receptor that has been functionally implicated in the regulation of energy homeostasis. Herein is described the development of indazole-based N-alkylthiazolidenediones, which function in biochemical

Process development for scale-up of a novel 3,5-substituted thiazolidine-2,4-dione compound as a potent inhibitor for estrogen-related receptor 1

Li, Xun,Russell, Ronald K.,Spink, Jan,Ballentine, Scott,Teleha, Christopher,Branum, Shawn,Wells, Kenneth,Beauchamp, Derek,Patch, Raymond,Huang, Hui,Player, Mark,Murray, William

, p. 321 - 330 (2014/03/21)

The development of a reproducible process for multihundred gram production of (Z)-5-((1-(4-chloro-2-(trifluoromethyl)benzyl)-1H-indazol-5-yl)methylene)-3- ((3R,4R)-3-fluoro-1-methylpiperidin-4-yl)thiazolidine-2,4-dione (26), a potent and selective inhibitor of estrogen-related receptor 1 (ERR1), is described. This multihundred gram synthesis was achieved via magnesium perchlorate- catalyzed regioselective epoxide ring-opening of tert-butyl 7-oxa-3- azabicyclo[4.1.0]heptane-3-carboxylate (9) with thiazolidine-2,4-dione (6, TZD) to form a diastereomeric mixture tert-butyl 4-(2,4-dioxothiazolidin-3-yl)-3- hydroxypiperidine-1-carboxylate (17), of which the 3-hydroxyl group was functionally transformed to 3-fluoro derivative 19 after treatment with Deoxo-Fluor. Chiral separation of 19 provided the desired diastereomer (3R,4R)-21 that was converted to the secondary amine 23 TFA salt. Reductive amination of 23 produced the key intermediate N-methyl 24. Knoevenagel condensation of 24 with 1-(4-chloro-2-(trifluoromethyl)benzyl)-1H-indazole-5- carbaldehyde (5) produced the final product 26 in 10% overall yield (99.7% HPLC area% with ≥99.5% de) after a convergent eight synthetic steps with the only column purification being the chiral HPLC separation of 3R,4R-21 from 3S,4S-22.

SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS

-

Page/Page column 148, (2011/06/28)

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS

-

, (2011/09/14)

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS

-

, (2011/09/14)

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS

-

Page/Page column 130-131; 133, (2011/12/13)

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1312704-84-9